Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Points to Consider in the Development of Seed Stocks of Pluripotent Stem Cells for Clinical Applications: International Stem Cell Banking Initiative (ISCBI)

12 Feb 2015

Abstract excerpt

In 2009 the International Stem Cell Banking Initiative (ISCBI) contributors and the Ethics Working Party of the International Stem Cell Forum published a consensus on principles of best practice for the procurement, cell banking, testing and distribution of human embryonic stem cell (hESC) lines for research purposes [1], which was broadly also applicable to human induced pluripotent stem cell (hiPSC) lines....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomedical Ethics and Regulation
Share to Pluripotent Stem Cells Research
Share to Renal and related cancers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25675265
DOI: 10.2217/rme.14.93

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Points to Consider in the Development of Seed Stocks of Pluripotent Stem Cells for Clinical Applications: International Stem Cell Banking Initiative (ISCBI)PMID 25675265Read ↗

Consensus Guidance for Banking and Supply of Human Embryonic Stem Cell Lines for Research PurposesSemantic proximity Read ↗

Requirements for human embryonic stem cellsSemantic proximity Read ↗

Access to stem cell data and registration of pluripotent cell lines: The Human Pluripotent Stem Cell Registry (hPSCreg)Semantic proximity Read ↗

The Procurement of Cells for the Derivation of Human Embryonic Stem Cell Lines for Therapeutic Use: Recommendations for Good PracticeSemantic proximity Read ↗

Quality Control Guidelines for Clinical-Grade Human Induced Pluripotent Stem Cell LinesSemantic proximity Read ↗

Recent Trends in Research with Human Pluripotent Stem Cells: Impact of Research and Use of Cell Lines in Experimental Research and Clinical TrialsSemantic proximity Read ↗

Current Applications of Human Pluripotent Stem Cells: Possibilities and ChallengesSemantic proximity Read ↗

Developing Standards to Support the Clinical Translation of Stem CellsSemantic proximity Read ↗

Adapting Cord Blood Collection and Banking Standard Operating Procedures for HLA-Homozygous Induced Pluripotent Stem Cells Production and Banking for Clinical ApplicationSemantic proximity Read ↗

Guidelines for human embryonic stem cell researchSemantic proximity Read ↗

Patents on Technologies of Human Tissue and Organ Regeneration from Pluripotent Human Embryonic Stem CellsSemantic proximity Read ↗

Two decades of embryonic stem cells: a historical overviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.